$HALB Halberd Corporation (OTC:HALB) President and CEO Bill Hartman and Chief Technology Officer Dr Mitchell Felder tell Proactive that the company has reached a significant milestone after its researchers demonstrated the ability to precisely control the level of PD-1 (programmed cell
https://www.youtube.com/watch?v=LQkWAuOASnc